Healthcare
ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Number of Shares Constituting the Share Capital
WOIPPY, France, August 27, 2026--Regulatory News: ABL Diagnostics: (Paris:ABLD)

About this update from Abl Diagnostics Sa
(Articles L. 233-8, II of the French Commercial Code and 223-16 of the AMF General Regulation) WOIPPY, France, August 27, 2026 --( BUSINESS WIRE )--Regulatory News: ABL Diagnostics: (Paris:ABLD) About ABL Diagnostics (ABLD) ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers: ABL Diagnostics markets its entire product range globally through its own sales team and a network of exclusive distributors active on all continents. ABL Diagnostics' customers are academic clinical pathology laboratories, private reference laboratories and researchers willing to implement innovative and robust microbiological content in constant expansion. Following the acquisition of TEXCELL's operations, ABL Diagnostics is expanding its activities in the life sciences sector by integrating expertise and services dedicated to virology, biosafety testing and biopharmaceutical development support. ABL Diagnostics has been marketing the products and services of its sister company CDL Pharma since the second half of 2025 through an intra-group strategy agreement. An expanding portfolio of microbiology products: Integrated Solutions ABL Diagnostics, headquartered in Woippy, is a public limited company listed on compartment B of the regulated market of Euronext in Paris (Euronext: ABLD – ISIN: FR001400AHX6). These molecular biology products generate recurring revenues and cover one of the largest portfolios of applications in microbiology. Public limited company with a capital of €1,611,465.60 Registered office: 72C route de Thionville - 57140 WOIPPY 552 064 933 R.C.S. METZ View source version on businesswire.com: https://www.businesswire.com/news/home/20260827980022/en/ Contacts ABL Diagnostics SA Société anonyme au capital de 1 611 465,60 euros Headquarters : 72C route de Thionville - 57140 WOIPPY 552 064 933 R.C.S. METZ Tel : +33 (0)7 83 64 68 50 Email : [email protected] https://www.abldiagnostics.com/
View stock analysis, news, and events for Abl Diagnostics Sa